Business
Avance Biosciences Launches NGS Center of Excellence in Houston
Avance Biosciences is proud to announce the launch of its Next-Generation Sequencing (NGS) Center of Excellence, a purpose-built facility designed to unify and enhance the company's sequencing capabilities across all phases of drug development. Located in Houston, the Center delivers comprehensive sequencing services to support research, preclinical and clinical studies, diagnostic support, and GMP-compliant testing for biologics and cell and gene therapies.
About this update from Illumina, Inc.
[{"type":"text","content":"Purpose-Built Facility Expands Sequencing Capabilities for Biologics and Cell and Gene Therapy Development","length":106,"tagName":"p"},{"type":"text","content":"HOUSTON, June 25, 2025 /PRNewswire/ -- Avance Biosciences is proud to announce the launch of its Next-Generation Sequencing (NGS) Center of Excellence, a purpose-built facility designed to unify and enhance the company's sequencing capabilities across all phases of drug development. Located in Houston, the Center delivers comprehensive sequencing services to support research, preclinical and clinical studies, diagnostic support, and GMP-compliant testing for biologics and cell and gene therapies.","length":510,"tagName":"p"},{"type":"image","alt":"Avance Biosciences Inc","displaySize":"","headline":null,"caption":"Avance Biosciences Inc","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":111,"url":"https://media.zenfs.com/en/prnewswire.com/e4f5fb2b83752853829f8d17389dcabd"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/hRUOMBwkPJnXi6TIbLvMcA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTE5NjtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/e4f5fb2b83752853829f8d17389dcabd","width":400,"height":111}},"href":"https://mma.prnewswire.com/media/2718177/Avance_Biosciences_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"The NGS Center of Excellence was established to meet the growing demand for advanced, regulatory-ready sequencing methods. It brings together an expansive suite of platforms, including Illumina, Element Biosciences, Oxford Nanopore, and PacBio for short- and long-read sequencing, alongside single-cell technologies such as 10x Genomics Chromium and Mission Bio's Tapestri. Supported by in-house bioinformatics and cross-functional scientific teams, the Center offers advanced sequencing solutions spanning GMP drug substance and product characterization, lot release, preclinical and clinical studies, CLIA-compliant assays, and diagnostics validation, supporting a wide range of drug modalities including biologics, RNA therapeutics, and cell and gene therapies.","length":768,"tagName":"p"},{"type":"text","content":""This is a major milestone for Avance Biosciences as we continue to support the evolving needs of biologics and cell and gene therapy developers," said Xuening Huang, CEO and ...